Phase 2 data show RAP-219 eases acute bipolar mania with significant YMRS gains and encouraging tolerability, setting the stage for FDA talks and phase 3 plans.
|Slideshows|October 17, 2018
Screen Time Solutions for Depression and Bipolar Disorder
Author(s)Chris Aiken, MD
Unremitting screen time worsens two systems that are already fragile in people with mood disorders-sleep and circadian rhythms.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Ozempic Dilemma: Promises and Pitfalls in Psychiatry
2
NDA Submission Complete: COMP360 Psilocybin for Treatment-Resistant Depression
3
Schizophrenia: A Telltale of the Brain’s Complexity
4
Talking With Titans: Sheldon Preskorn, MD, on the Evolution of Psychopharmacology
5